EUVIMEDEUVIMED entdecken
Crossref

Triple‐Tailored Analgesic Hydrogel System Targeting ADAM17 in Orofacial Inflammatory Pain

Yingyu Yi, Yuxuan Wu, Yanghong Xu, Zhengjie Han, Yuzhuo Wang, Jianwen Gong, Yubin Hu, Xinzhao Mai, Weizhe Sheng, Junting Li, Yujie Chen, Zhi Yang iD und 1 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202501440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yingyu Yi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, National…. Hauptthemen laut MEDLINE: Hydrogels, Facial Pain, ADAM17 Protein, Analgesics. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orofacial inflammatory pain (OFP) is challenging to manage due to its high incidence, complex anatomy, and multifactorial etiology. To address this, a three‐step customized therapeutic system is proposed for prolonged pain relief and efficient local drug delivery. First, ADAM17 is identified as a novel therapeutic target for OFP, and find a small‐molecule inhibitor, TAPI‐1, which can effectively suppress ADAM17 activity. Subsequently, guided by the presence of an amine group on TAPI‐1, an optimized hydrogel matrix is synthesized via Schiff‐base bonding to enable stable encapsulation. The hydrogel, composed of hyaluronic acid derivatives carrying aldehyde (HAALD) and aminated gelatin (AGel), forms a scaffold that slows drug release. Second, for clinical application in orofacial tissue, unmodified hyaluronic acid (HA) and gelatin are incorporated to optimize the hydrogel's rheological properties for practicable injection. Third, to further prolong drug release, customized hollow mesoporous silica nanoparticles are added to trap a portion of TAPI‐1, matching the drug's molecular diameter. This triple‐tailored sustained‐release hydrogel (HHGA hydrogel) maintains effective drug levels for 7 days, aligning with the pain phase and obviously relieving pain in mice. This “drug‐device” innovation exemplifies the potential of personalized medicine in pain management and targeted therapies in translational medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsFacial PainADAM17 ProteinAnalgesicsAnimalsMiceHyaluronic AcidGelatinDrug Delivery SystemsInflammationNanoparticlesMaleDrug LiberationHumans

Stichwörter der Autor:innen

ADAM17hydrogelsnanoparticlesorofacial inflammatory pain

Substanzen

HydrogelsADAM17 ProteinHyaluronic AcidAnalgesicsGelatin

Autor:innen und Institutionen

  • Department of General Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Di…
  • State Key Laboratory of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Jiao Tong University, 200240, Shanghai, China.
  • Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, 200031, Shanghai, China.
  • Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory o…
  • University of Chinese Academy of Sciences, 100049, Beijing, China.
  • School of Life Science and Technology, ShanghaiTech University, 201210, Shanghai, China.

ORCID-Profile: Zhi Yang, Yaqin Zhu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Jiao Tong University

Zitieren

APA

Yi, Y., Wu, Y., Xu, Y., Han, Z., Wang, Y., Gong, J., Hu, Y., Mai, X., Sheng, W., Li, J., Chen, Y., Yang, Z., & Zhu, Y. (2025). Triple‐Tailored Analgesic Hydrogel System Targeting ADAM17 in Orofacial Inflammatory Pain. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501440

Vancouver

Yi Y, Wu Y, Xu Y, Han Z, Wang Y, Gong J, et al. Triple‐Tailored Analgesic Hydrogel System Targeting ADAM17 in Orofacial Inflammatory Pain. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501440

BibTeX
@article{Yi2025,
  author = {Yi, Yingyu and Wu, Yuxuan and Xu, Yanghong and Han, Zhengjie and Wang, Yuzhuo and Gong, Jianwen and Hu, Yubin and Mai, Xinzhao and Sheng, Weizhe and Li, Junting and Chen, Yujie and Yang, Zhi and Zhu, Yaqin},
  title = {Triple‐Tailored Analgesic Hydrogel System Targeting ADAM17 in Orofacial Inflammatory Pain},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202501440}
}
Kostenlos starten →